Clinical performance of GAAD score, alpha-fetoprotein, and PIVKA-II in diagnosing hepatocellular carcinoma in the Vietnamese cohort
This study in Vietnam revealed the performance of GAAD and PIVKA-II plus AFP in the HCC screening strategy. These strategies appeared effective for HCC patients regardless of tumor size (≤ 2 cm) or patient age (≥ 50). Further study is encouraged to confirm these findings.
Authors
- Dat Tan Ho (ORCID: https://orcid.org/0009-0002-4304-4452)
- Hải Phan Thanh (ORCID: https://orcid.org/0000-0003-2176-9153)
- Toan Bao Nguyen
- Thuy Thi Thu Pham
Institutions
- Thai Nguyen National General Hospital (VN)
- University Medical Center HCMC (VN)
- Thai Nguyen University (VN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1007/s12672-025-03651-4
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00